For the first time, each product sold in pharmacies, supermarkets and e-commerce can begin a direct relationship with whoever buys it — without integrating anything with retail.
Leading the transition from "Traditional Pharma" to "Symbiotic Health".
Three structural gaps that no marketing campaign solves:
The brand sells to the channel, not to the patient. You don't know who buys, how often or from which pharmacy. Amazon and MELI already know your consumer better than you.
Only 50% of chronic patients complete their treatment. Without post-purchase digital link, abandonment is invisible and silent for the laboratory.
Without digital differential, any generic or other competing brand wins with a 5% discount. The brand invests in R&D and loses sales due to price, not quality.
WAIO transforms each product in its laboratory into the entry point to a direct and continuous relationship with the consumer-patient.
Through a simple promotional claim in the channel (a stopper in the pharmacy, a banner in e-commerce or a doctor's brochure), the consumer is informed that with their purchase they receive gift access to your own Wellbeing Operating System.
The consumer discovers the benefit at the point of sale or through his or her doctor. Buy the product normally and, by scanning the ticket on the website, activate your Wellbeing Operating System —a digital ecosystem of +30 professional wellness apps, personalized with the branding of your laboratory.
Access has a configurable duration depending on the objective. When it expires, the patient buys again. The product is the subscription.
The consumer only photographs their purchase receipt. The AI verifies that you purchased your product and delivers access. No QR in the pack. Without coordination with the point of sale. Operational today.
Compatible with: Carrefour, Coto, Día, Farmacity and any Argentine tax ticket.
The laboratory reports the benefit through multiple means. The consumer purchases normally and activates with the ticket validator. It does not require anything from retail.
Designed to empower the APM in their 3 minute visit. We give the sales force a “superpower”: the APM shows off by delivering a self-explanatory “digital free sample.” The doctor provides instant value without consuming time, and the APM establishes itself as its strategic partner, protecting its prescription against generics — The patient must autonomously purchase the brand to obtain the benefit.
The APF is the commercial star: arrives offering a solution of profitability and loyalty. The physical POP makes communication with zero burden for the employee. The customer scans and takes away a co-branded digital counter (50% Laboratory / 50% Pharmacy). The system generates local repurchase by retaining the customer at that same counter through WhatsApp.
The stopper on the gondola communicates the profit. The client purchases normally and activates with the validator. Zero coordination with Carrefour, Coto or Día. The claim "Activate 30 days of the Wellness Operating System" on the label is worth $15–$20 USD received — differentiation without discount.
Digital channels are the most efficient to communicate the benefit: they do not require physical material, the link to the validator is just one click away, and the laboratory can update the message in real time.
The differentiating claim already on the product sheet drives the sale and wins the purchase decision over competitors and generics. Without printing anything. Without coordinating anything with the marketplace.
Any post, story or reel can report the benefit. The laboratory does not change its content strategy — it adds a digital claim to what it already publishes. The consumer who sees the post buys the product and activates it. The social network is the awareness channel, the Wellbeing Operating System is the closure.
The laboratory's existing database (HCPs, patients from previous programs, subscribers) can receive the benefit by email or WhatsApp. Zero claim distribution cost.
💡 The code in the pack is an optional option for absolute traceability by unit and lot — it is not necessary for the system to function. The ticket validator does it all. No printing, no designing, no additional production.
WAIO does not "jump" into the sales force, it makes it the main protagonist. It gives the laboratory a digital asset so that its APMs and APFs can shine in front of each actor in the channel, acting as the ideal strategic partner that solves key problems for them — without direct investment.
The APM shines by offering an immediate "digital sample" that prioritizes the office without requiring a second of explanation from the professional. For the Laboratory, it empowers its sales force with a lethal anti-substitution barrier under a model of zero initial risk and USD 0.50 tied exclusively to success.
A turnkey "Digital Defense Shield". The APF of the Laboratory becomes an untouchable ally by offering this PWA (with WhatsApp orders exclusive to that location) as its "superpower" and bargaining chip to negotiate stock volume and priority display on the shelf compared to the large chains.
A shelf stopper with real value that allows you to maintain the list price without entering into a discount war. The claim "Activate your Wellbeing Operating System" justifies the premium price compared to white brands.
A differentiator in the product sheet within MercadoLibre, Farmacity.com or any marketplace. Competitors and generics do not have it. The digital claim does not require production or coordination.
In all cases, the marginal cost for the laboratory is minimal or zero. What changes in each channel is the incentive argument — not the technical mechanism. WAIO always works the same.
There is no fixed term. The duration of access is configured by product, channel and strategic objective. The same system serves both to generate repurchases and to accompany long-term treatments.
Short term (e.g. 30 days). When it expires, the consumer wants to continue using the Wellness OS → repurchases the product. Expired access is the best call-to-action.
Medium term (e.g. 90 days). It accumulates for each additional purchase. The patient with 3 purchases has 270 days of access — adherence measured in real time.
Long term (e.g. 12 months). The laboratory sends the code directly to the enrolled patient. Without seeking a buyback — the focus is to accompany, measure adherence and generate RWE.
Extended term for high ticket products (e.g. 6 months). Greater perceived value in gondola. Justifies premium price compared to competitors and generics.
The duration and number of uses per code are configured per product — with no additional development for the lab.
For each activation, the laboratory captures the email and WhatsApp of the real consumer, the purchase channel and the repurchase frequency. Without intermediaries. The database is from the laboratory, not from retail.
See example of traceabilityAccess has an expiration date. The patient who wants to maintain his progress needs to buy again. The repurchase cycle is built into the product.
The use of the system naturally generates data on adherence, treatment combinations and post-purchase behavior. As a critical mass of users accumulates, this dataset becomes a strategic asset for the laboratory — available for analysis and R&D according to the agreements defined in each implementation.
"With this product you activate 30 days of the Wellbeing Operating System for free" is worth $15–$20 USD received. The product competes on value, not discount.
USD 0.50 per successful activation.
No setup. No monthly licenses. The laboratory only pays when a real consumer activates their access.
No activation
The consumer purchased and did not activate. The laboratory won the sale and paid nothing to WAIO. The gondola claim still improved the conversion.
With activation
For USD 0.50 you get First-Party Data, measured adherence and direct channel. $10 product → $10 buyback = 20x ROI.
| Metrics | Meta / Google Ads | WAIO |
|---|---|---|
| Cost per identified user | USD 15 — 55 | USD 0.50 |
| Efficiency vs. digital channel | Baseline 1x | 30x — 110x better |
| Relationship with consumer | Anonymous / intermediated | Direct — 1st Party |
| Technical setup | High IT investment | Zero — turnkey |
Scientific Validation
Research on the impact of AI on public and private health cost reduction.
Randomized clinical trial approved by the Ethics Committee. 2,000 participants.
Academic and institutional framework of the comprehensive well-being model.
Intellectual Property
🔒 USPTO/PCT Patent — Physical-digital method in process.
📊 Data Moat — Longitudinal behavioral datasets that are difficult to replicate.
🏷️ Registered Trademarks — 4 international classes (9, 32, 41, 42).
🔐 Zero-Knowledge Architecture — Privacy GDPR/LGPD by design.
15+ years in B2B SaaS scalability and financial management (CPA/MBA). Doctoral Candidate (PhD) in Systemic Innovation — ITBA.
Technical leadership in AI, Cloud and PWA. 14 years as founder managing complex B2B operations, supply chain and industrial retail.
Reference Pediatric Cardiac Surgeon. Elizalde Hospital. Co-founder AVATAR MedTech. RCT protocol supervisor.
Nuclear Engineer (Balseiro Institute), Doctor in Engineering, Former Rector of ITBA. Robustness of data architecture.
WAIO is operational, scientifically validated and coordinating pilots with leading laboratories in Argentina. The cost of not acting is remaining invisible in your consumer's daily lives.
The demo is free, but you need a code to enter.
If you don't have it, ask us for it on WhatsApp — we'll send it to you instantly.
WAIO — JUNE 2026 — CONFIDENTIAL